Raymond James & Associates’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$10.1M Buy
396,463
+55,531
+16% +$1.4M 0.01% 1228
2024
Q2
$8.44M Buy
340,932
+33,175
+11% +$818K 0.01% 1262
2024
Q1
$7.66M Buy
307,757
+52,473
+21% +$1.31M 0.01% 1306
2023
Q4
$6.41M Buy
255,284
+94,390
+59% +$2.29M ﹤0.01% 1372
2023
Q3
$3.87M Buy
160,894
+59,409
+59% +$1.45M ﹤0.01% 1621
2023
Q2
$2.49M Sell
101,485
-773
-0.8% -$19.1K ﹤0.01% 1917
2023
Q1
$2.55M Buy
102,258
+18,526
+22% +$457K ﹤0.01% 1890
2022
Q4
$2.03M Buy
83,732
+2,018
+2% +$48.6K ﹤0.01% 1973
2022
Q3
$1.94M Buy
81,714
+907
+1% +$22.6K ﹤0.01% 1977
2022
Q2
$2.02M Sell
80,807
-1,140
-1% -$28.9K ﹤0.01% 1976
2022
Q1
$2.16M Buy
81,947
+2,097
+3% +$57K ﹤0.01% 2077
2021
Q4
$2.26M Sell
79,850
-54,440
-41% -$1.55M ﹤0.01% 2092
2021
Q3
$3.85M Sell
134,290
-2,582
-2% -$74.8K ﹤0.01% 1669
2021
Q2
$3.96M Buy
136,872
+8,584
+7% +$246K ﹤0.01% 1643
2021
Q1
$3.63M Sell
128,288
-2,994
-2% -$86.5K ﹤0.01% 1630
2020
Q4
$3.88M Buy
131,282
+26,112
+25% +$764K ﹤0.01% 1477
2020
Q3
$3.06M Sell
105,170
-22,203
-17% -$650K ﹤0.01% 1497
2020
Q2
$3.67M Buy
127,373
+23,582
+23% +$656K ﹤0.01% 1374
2020
Q1
$2.72M Sell
103,791
-54,141
-34% -$1.5M ﹤0.01% 1400
2019
Q4
$4.38M Buy
157,932
+70,238
+80% +$1.95M 0.01% 1339
2019
Q3
$2.43M Buy
+87,694
New +$2.41M ﹤0.01% 1655

Other funds holding IBDT

Raymond James & Associates's IBDT Position: Q3 2024 in Review

Raymond James & Associates increased its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 16% in Q3 2024, buying an estimated $1.4M and bringing the position to 396,463 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #1228.

Raymond James & Associates first reported a position in IBDT in Q3 2019 and has held it in 21 quarters since. 291 funds tracked by Wall St. Rank hold IBDT as of Q3 2024.

  • Raymond James & Associates held 396,463 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $10.1M as of Q3 2024.
  • Raymond James & Associates bought 55,531 iShares iBonds Dec 2028 Term Corporate ETF shares in Q3 2024, an estimated $1.4M.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1228 holding.
  • Raymond James & Associates first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q3 2019 and has held it in 21 quarters since.
  • 291 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.